Atara Biotherapeutics, Inc. (NASDAQ: ATRA) saw a significant rebound on Tuesday during the after-market session, rising 16.15% to $7.91. The ATRA stock finished at $6.81
Atara Biotherapeutics, Inc. (ATRA) declined in the after-hours market after announcing that Memorial Sloan Kettering Cancer Center (MSK) notified the FDA of a patient’s death
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.